Despite hemopexin failing to demonstrate its value as an indicator of cirrhosis, SIPA1L1 showed a clear serum diminution and a great accuracy at identifying early fibrotic stages in the validation group. This evidence concerns the gene SIPA1L1 and Cirrhosis.